ForeverLabs
0%
ClinicalStroke recoveryStroke

Mesenchymal stem cell transplantation as an effective treatment strategy for ischemic stroke in Asia: a meta-analysis of controlled trials

PubMed

Key Findings

MSC therapy is safe and effective in treating IS by improving the neurological deficits, motor function and daily life quality of patients..

AI generated image for: Mesenchymal stem cell transplantation as an effective treatment strategy for ischemic stroke in Asia: a meta-analysis of controlled trials

MSC therapy is safe and effective in treating IS by improving the neurological deficits, motor function and daily life quality of patients.

Research Details

Source

PubMed

Publication Date
Categories & Tags
ClinicalStroke recoveryStroke
View Original Publication

Cite this article: PubMed. "Mesenchymal stem cell transplantation as an effective treatment strategy for ischemic stroke in Asia: a meta-analysis of controlled trials". Published August 11, 2025. Available at: https://pubmed.ncbi.nlm.nih.gov/29785117/

Access Original Research

View the complete study and detailed methodology from the original source.

Read Full Study↗
← All Articles← Clinical Articles

You Might Also Like

Explore more articles in this category

AI generated image for: Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial
1 min

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial

This phase II randomized trial demonstrates that autologous hematopoietic stem cell transplantation (AHSCT) is significantly more effective than mitoxantrone at reducing MRI-detected disease activity in patients with aggressive multiple sclerosis. Results showed a 79% reduction in new T2 lesions and a significant decrease in relapse rates, supporting the need for larger phase III clinical trials.

Neurology
AI generated image for: Effect of aging on stem cells
1 min

Effect of aging on stem cells

As we age, stem cells lose efficacy and ability to heal.

NIH
AI generated image for: Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease
1 min

Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease

Intravenous transplantation of bone marrow-derived mononuclear cells (BMMCs) successfully improved cognitive function and prevented neurodegeneration in two different Alzheimer's disease mouse models.

PubMed